Stocks

As legacy European automakers have been significantly hit by Trump's tariffs, Stellantis N.V. (NYSE:STLA) is finally attempting a bold move to potentially get ahead of its competition. The Netherlands-based company announced on Wednesday morning its plans to invest $388 million to build a spare …

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock. By their very nature, these stocks carry above-average risk and volatility. …

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all. That's because, these stocks usually carry above-average risk and volatility. …

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock. By their very nature, these stocks carry above-average risk and volatility. …

US equity indexes traded mixed after gains in Alphabet's (GOOG, GOOGL) shares helped lift the Nasdaq PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already …

Shares of Cincinnati Financial Corporation CINF have gained 4.5% year to date, underperforming the industry’s 11.8% growth and the Finance sector’s return of 5.7%. The insurer outperformed the Zacks S&P 500 composite’s rise of 0.2% in the same time frame. The stock is trading …

Bayer AG BAYRY announced that it has initiated a phase I study, which is evaluating its investigational highly selective GIRK4 inhibitor, BAY 3670549, for the treatment of patients with atrial fibrillation (AFib). The double-blind, placebo-controlled first-in-human dose escalation study will evaluate safety, tolerability, pharmacokinetics …